Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

An Adaptive Design Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Emapalumab in Adult Patients with Non-Primary Hemophagocytic Lymphohistiocytosis

Veronica Asnaghi, MD, Maria Ballabio, MD, Philippe Jacqmin, Kathy de Graaf, Cristina De Min, MD

Blood (2019) 134 (Supplement_1): 2333.

https://doi.org/10.1182/blood-2019-123995

Published: 2019

Journal Articles

Outcome of Children with Primary Immune-Deficiencies (PIDs) Enrolled in a Phase I-II Trial Based on the Infusion of BPX-501 Donor T Cells Genetically Modified with a Novel Suicide Gene (inducible Caspase 9, iC9) after T-Cell Depleted HLA-Haploidentical Allogeneic Stem Cell Transplantation (haplo-HSCT)

Neena Kapoor, MD, Alice Bertaina, MD PhD, Pietro Merli, MD, Swati Naik, MD, Waseem Qasim, MBBS PhD, Mary Slatter, MD, Reem Elfeky, MD, Barbarella Lucarelli, MD, Monika Smogorzewska, PhD, Giuseppina Li Pira, PhD, Valentina Bertaina, PhD, Annemarie Moseley, MD PhD, Franco Locatelli, MD

Blood (2016) 128 (22): 72.

https://doi.org/10.1182/blood.V128.22.72.72

Published: 2016

Journal Articles

Natural Toll-like Receptor Agonists for in Situ Vaccination Lymphoma Immunotherapy

Paul Peng, PhD, Joshua Brody, MD, Linda Hammerich, PhD

Blood (2015) 126 (23): 4002.

https://doi.org/10.1182/blood.V126.23.4002.4002

Published: 2015

Journal Articles

An Optimized, Ex Vivo Log-Scale Expansion of UCB-Derived Myeloid Dcs, Towards Efficient Cancer Immunotherapy

Eleni Gounari, Anastasia Papadopoulou, PhD, Minas Yiangou, Prof, Angeliki E Xagorari, PhD, Achilles Anagnostopoulos, MD, Evangelia Yannaki, MD, Panayotis Kaloyannidis, MD

Blood (2014) 124 (21): 2441.

https://doi.org/10.1182/blood.V124.21.2441.2441

Published: 2014

Journal Articles

Reduced Intensity Hematopoietic Stem Cell Transplant Rescues Immune Function and Corrects Pulmonary Alveolar Proteinosis in DCML Deficiency/GATA 2 Mutation

Blood (2011) 118 (21): 2045.

https://doi.org/10.1182/blood.V118.21.2045.2045

Published: 2011

Journal Articles

A Novel Mutation K673R In STAT1 Impaired the STAT1 Signal Transduction In a dominant– Negative Manner Identified In a Japanese Boy with MSMD

Yoko Mizoguchi, MD, Miyuki Tsumura, B.Sc., Satoshi Okada, MD, Hidemasa Sakai, MD, Ryuta Nishikomori, MD, Shin'ichiro Yasunaga, MD, Motoaki Ohtsubo, PhD, Takuji Murata, MD, Hideto Obata, MD, Takahiro Yasumi, MD, Toshio Heike, MD, Tatsutoshi Nakahata, MD, Yoshihiro Takihara, MD, Masao Kobayashi, MD

Blood (2010) 116 (21): 1734.

https://doi.org/10.1182/blood.V116.21.1734.1734

Published: 2010

Journal Articles

Exosomes released from macrophages infected with intracellular pathogens stimulate a proinflammatory response in vitro and in vivo

Sanchita Bhatnagar, Kazuhiko Shinagawa, Francis J. Castellino, Jeffrey S. Schorey

Blood (2007) 110 (9): 3234–3244.

https://doi.org/10.1182/blood-2007-03-079152

Published: 2007

Journal Articles

A Novel Mutation 774del4 in IFNGR1 , Which Produces Truncated Form of Interferon γ Receptor 1, Causes a Dominant-Negative Effect on Interferon γ Signal Transduction.

Satoshi Okada, MD, Nobutsune Ishikawa, M.D., Kenichirou Shirao, M.D., Hiroshi Kawaguchi, M.D., Miyuki Tsumura, Ph.D., Yoshinori Ohno, Ph.D., Shin’ichiro Yasunaga, Ph.D., Motoaki Ohtsubo, Ph.D., Yoshihiro Takihara, Ph.D., Masao Kobayashi, M.D.

Blood (2006) 108 (11): 1246.

https://doi.org/10.1182/blood.V108.11.1246.1246

Published: 2006

Journal Articles

Multicolor Fluorescence In Situ Hybridization (M-FISH) in Highly Aggressive B-Cell Lymphomas with 8q24/MYC Involvement Revealed the Heterogeneity of 13q Abnormalities with Unexpected Partial Gains.

Violaine Havelange, Geneviève Ameye, Evelyne Callet-Bauchu, Nicole Dastugue, Carole Barin, Dominique Penther, Lucienne Michaux, Anne Hagemeijer, Miikka Vikkula, Hélène Antoine-Poirel

Blood (2006) 108 (11): 2068.

https://doi.org/10.1182/blood.V108.11.2068.2068

Published: 2006

Journal Articles

A randomized comparison of postremission therapy in acute myelogenous leukemia: a Southeastern Cancer Study Group trial

WR Vogler, EF Winton, DS Gordon, MR Raney, B Go, L Meyer

Blood (1984) 63 (5): 1039–1045.

https://doi.org/10.1182/blood.V63.5.1039.1039

Published: 1984

NARROW

An Adaptive Design Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Emapalumab in Adult Patients with Non-Primary Hemophagocytic Lymphohistiocytosis

Natural Toll-like Receptor Agonists for in Situ Vaccination Lymphoma Immunotherapy

An Optimized, Ex Vivo Log-Scale Expansion of UCB-Derived Myeloid Dcs, Towards Efficient Cancer Immunotherapy

Reduced Intensity Hematopoietic Stem Cell Transplant Rescues Immune Function and Corrects Pulmonary Alveolar Proteinosis in DCML Deficiency/GATA 2 Mutation

A Novel Mutation K673R In STAT1 Impaired the STAT1 Signal Transduction In a dominant– Negative Manner Identified In a Japanese Boy with MSMD

Exosomes released from macrophages infected with intracellular pathogens stimulate a proinflammatory response in vitro and in vivo

A Novel Mutation 774del4 in IFNGR1 , Which Produces Truncated Form of Interferon γ Receptor 1, Causes a Dominant-Negative Effect on Interferon γ Signal Transduction.

Multicolor Fluorescence In Situ Hybridization (M-FISH) in Highly Aggressive B-Cell Lymphomas with 8q24/MYC Involvement Revealed the Heterogeneity of 13q Abnormalities with Unexpected Partial Gains.

A randomized comparison of postremission therapy in acute myelogenous leukemia: a Southeastern Cancer Study Group trial

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only